RFI-641

N/A

Report date: 2022/05/05 09:55:01

NME

Base Information

Drug NameRFI-641

Drug Alias NameRFI-641WAY-154641CL-387626

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionViral fusion proteins inhibitors

TargetsViral fusion proteins

Therapy Area/IndicationsRespiratory Syncytial Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsRespiratory Syncytial Virus Infections

ATC CodeN/A